CVS Health (NYSE:CVS – Free Report) had its price objective increased by Morgan Stanley from $93.00 to $106.00 in a research note published on Thursday morning, MarketBeat reports. Morgan Stanley currently has an overweight rating on the pharmacy operator’s stock. Several other equities research analysts have also issued reports on the company. The Goldman Sachs […]

AMN Healthcare Services (NYSE:AMN – Get Free Report) had its price objective lifted by research analysts at Robert W. Baird from $23.00 to $26.00 in a research report issued on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Robert W. Baird’s price objective indicates a potential downside of 9.88% from the […]